
The iSono Health has developed the world’s first AI-driven platform with an automated, portable, and wearable ultrasound to empower women and their physicians with early breast cancer detection and monitoring. Our patented compact ultrasound scanner captures 3D images by automatically scanning the whole breast volume in 2 minutes. The device connects to a smartphone/tablet/laptop. The data is transferred to a secure cloud for image processing and storage. Our machine-learning algorithm uses acoustic biomarkers to identify abnormal masses. Our platform’s automated operation and software expand ultrasound use in point-of-care diagnostics and monitoring of breast health at radiology centers, walk-in, and mobile clinics. iSono Health offers women and healthcare providers : Safety: No Radiation Actionable Feedback with AI Fast: 2min Scan Easy to Use

The iSono Health has developed the world’s first AI-driven platform with an automated, portable, and wearable ultrasound to empower women and their physicians with early breast cancer detection and monitoring. Our patented compact ultrasound scanner captures 3D images by automatically scanning the whole breast volume in 2 minutes. The device connects to a smartphone/tablet/laptop. The data is transferred to a secure cloud for image processing and storage. Our machine-learning algorithm uses acoustic biomarkers to identify abnormal masses. Our platform’s automated operation and software expand ultrasound use in point-of-care diagnostics and monitoring of breast health at radiology centers, walk-in, and mobile clinics. iSono Health offers women and healthcare providers : Safety: No Radiation Actionable Feedback with AI Fast: 2min Scan Easy to Use
Product: ATUSA — AI-enabled, portable automated 3D breast ultrasound scanner and software
Regulatory: Company website indicates ATUSA has FDA 510(k) clearance
Founders: Co‑founders Maryam Ziaei (CEO) and Shadi Saberi (Co‑founder & CTO)
Use case: Point-of-care whole-breast scans and longitudinal breast health monitoring
Breast cancer screening, diagnostic imaging, and longitudinal breast health monitoring at point-of-care settings.
Medical Equipment Manufacturing
Seed round listed with Foothill Ventures as lead; investors include Plexo Capital and Draper Associates.
Multiple NSF grant entries listed in funding records.
Y Combinator listed as an early backer (pre-seed).
“Backed by grants and early-stage investors including National Science Foundation, Y Combinator, Foothill Ventures, Draper Associates, Plexo Capital”